Catalyst Wire Dossier Catalyst Wire Dossier

CBT102-A

· Children's Hospital of Fudan University
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CBT102-A, covering 2026-02-27 to 2026-02-27. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy and Safety of Orally Administered Engineered Probiotics (CBT102-A) for the Treatment of Children With Phenylketonuria [EARLY_Phase 1]

See pricing